Robert Chess serves as Executive at NEKTAR THERAPEUTICS, where they oversee executive responsibilities. Since joining the company, Robert Chess has executed 107 insider transactions totaling $12.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 14, 2008 involved exercising options for 9,167 shares valued at $0.
Robert Chess currently holds 255,273 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Chess has been a net seller of NKTR stock. They have purchased $0 and sold $12.2M worth of shares.
Robert Chess's most recent insider trade was on Nov 14, 2008, when they sold 9,167 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.23 |
| Discretionary |
| Mar 19, 2007 | NKTR | $0 | Award | 52,083 | $N/A | Discretionary |
| Jan 8, 2007 | NKTR | $52.1K | Sale | 3,592 | $14.51 | Discretionary |
| Jan 3, 2007 | NKTR | $0 | Award | 8,334 | $N/A | Discretionary |
| Mar 7, 2006 | NKTR | $43.8K | Sale | 2,210 | $19.80 | Discretionary |
| Mar 3, 2006 | NKTR | $0 | Award | 5,555 | $N/A | Discretionary |